Supporting the scientific study of sharks, skates and rays since 1983.
Only one of the vaccines, PCV13, is considered safe for children under the age of 2, This vaccine is important because infants and very young children are at higher risk for several dangerous infections, including pneumonia and bacterial meningitis.
Children who have received one or more doses of Prevnar may complete the 4-dose immunization series with Prevnar 13. Children 15 months through 5 years of age who have received 4 doses of Prevnar may receive one dose of Prevnar 13 to elicit immune responses to the six additional serotypes. This catch-up dose of Prevnar 13 should be administered with an interval of at least 8 weeks after the fourth dose of Prevnar.